Abildgaard, M. O., Borre, M., Mørck Mortensen, M., Ulhøi, B. P., Tørring, N., Wild, P.
, Kristensen, H., Mansilla, F., Ottosen, P. D., Andersen, L. D., Orntoft, T. F. & Dalsgaard Sørensen, K. (2012).
Downregulation of ZNF132 in prostate cancer is associated with aberrant promoter hypermethylation and poor prognosis.
International Journal of Cancer,
130(4), 885-895.
https://doi.org/10.1002/ijc.26097
Villadsen, S. B., Bramsen, J. B., Ostenfeld, M. S., Wiklund, E. D., Fristrup, N., Gao, S., Hansen, T. B., Jensen, T. I., Borre, M., Orntoft, T. F., Dyrskjøt, L. & Kjems, J. (2012).
The miR-143/-145 cluster regulates plasminogen activator inhibitor-1 in bladder cancer.
B J C,
106(2), 366-374.
https://doi.org/10.1038/bjc.2011.520
Wang, G., Yuan, W., Kwon, T.-H.
, Li, Z., Wen, J.
, Topcu, S. O., Djurhuus, J. C., Nielsen, S. & Frøkiær, J. (2012).
Age-related changes in expression in renal AQPs in response to congenital, partial, unilateral ureteral obstruction in rats.
Pediatric Nephrology,
27(1), 83-94.
https://doi.org/10.1007/s00467-011-1878-x
Cek, M., Tandoğdu, Z., Naber, K., Tenke, P., Wagenlehner, F., van Oostrum, E.
, Kristensen, B., Johansen, T. E. B. & on behalf of the Global Prevalence Study of Infections in Urology Investigators (2012).
Antibiotic Prophylaxis in Urology Departments, 2005-2010.
European Urology (Italian Edition).
https://doi.org/10.1016/j.eururo.2012.09.038Fristrup, N., Ulhøi, B. P., Birkenkamp-Demtröder, K., Mansilla, F., Sanchez-Carbayo, M., Segersten, U., Malmström, P.-U., Hartmann, A., Palou, J., Alvarez-Múgica, M.
, Zieger, K., Borre, M., Ørntoft, T. F. & Andersen, L. D. (2012).
Cathepsin E, maspin, Plk1, and survivin are promising prognostic protein markers for progression in non-muscle invasive bladder cancer.
American Journal of Pathology,
180(5), 1824-34.
https://doi.org/10.1016/j.ajpath.2012.01.023
Holland-Bill, L., Frøslev, T., Friis, S.
, Olsen, M., Harving, N., Borre, M. & Søgaard, M. (2012).
Completeness of bladder cancer staging in the Danish Cancer Registry, 2004-2009.
Clinical Epidemiology,
4(S2), 25-31.
https://doi.org/10.2147/CLEP.S31542
Nguyen Nielsen, M., Frøslev, T., Friis, S.
, Borre, M., Harving, N. & Søgaard, M. (2012).
Completeness of prostate cancer staging in the Danish Cancer Registry, 2004-2009.
Clinical Epidemiology,
4(S2), 17-23.
https://doi.org/10.2147/CLEP.S32004
Niemann, A. K., Thrysoe, S., Nygaard, J. V., Hasenkam, M. & Petersen, S. E. (2012).
Computational Fluid Dynamics simulation of a-v fistulas: From MRI and ultrasound scans to numeric evaluation of hemodynamics.
Journal of Vascular Access,
13(1), 36-44.
https://doi.org/10.5301/JVA.2011.8440
Borre, M., Høyer, M., Friis, S., Hansen, S., Brasso, K.
, Petersen, A., Nørgaard, M., Olsen, M. S. & Bartels, P. (2012).
DaProCadata - Dansk Prostatacancer Database.
Ugeskrift for Læger,
174(42), 2556.
Reinert, T., Borre, M., Christiansen, A., Hermann, G.
, Orntoft, T. F. & Andersen, L. D. (2012).
Diagnosis of Bladder Cancer Recurrence Based on Urinary Levels of EOMES, HOXA9, POU4F2, TWIST1, VIM, and ZNF154 Hypermethylation.
PLoS One,
7(10), e46297.
https://doi.org/10.1371/journal.pone.0046297
Ravlo, K., Chhoden, T.
, Søndergaard, P., Secher, N., Keller, A. K., Pedersen, M., Bibby, B. M., Jørgensen, T. M., Møldrup, U., Østraat, Ø., Birn, H., Nørregaard, R., Marcussen, N., Leuvenink, H. G.
& Jespersen, B. (2012).
Early outcome in renal transplantation from large donors to small and size-matched recipients - a porcine experimental model.
Pediatric Transplantation,
16(6), 599-606.
https://doi.org/10.1111/j.1399-3046.2012.01707.x
Ravlo, K., Koefoed-Nielsen, P. B., Secher, N., Søndergaard, P., Keller, A. K., Petersen, M. S., Møldrup, U., Østraat, Ø., Bibby, B. M., Jørgensen, T. M., Tønnesen, E. & Jespersen, B. (2012).
Effect of remote ischemic conditioning on dendritic cell number in blood after renal transplantation - flow cytometry in a porcine model.
Transplant Immunology,
26(2-3), 146-50.
https://doi.org/10.1016/j.trim.2011.10.006
Wagenlehner, F. M. E., Cek, M., Naber, K. G., Kiyota, H.
& Johansen, T. E. B. (2012).
Epidemiology, treatment and prevention of healthcare-associated urinary tract infections.
World Journal of Urology,
30(1), 59-67.
https://doi.org/10.1007/s00345-011-0757-1Andersen, L. D., Zieger, K., Kissow Lildal, T., Reinert, T., Gruselle, O., Coche, T.
, Borre, M. & Ørntoft, T. F. (2012).
Expression of MAGE-A3, NY-ESO-1, LAGE-1 and PRAME in urothelial carcinoma.
B J C,
107(1), 116-22.
https://doi.org/10.1038/bjc.2012.215
Laurberg, J. R., Brems-Eskildsen, A. S., Nordentoft, I., Fristrup, N., Schepeler, T., Ulhøi, B. P., Agerbaek, M., Hartmann, A., Bertz, S., Wittlinger, M., Fietkau, R., Rödel, C.
, Borre, M., Jensen, J. B., Orntoft, T. & Andersen, L. D. (2012).
Expression of TIP60 (tat-interactive protein) and MRE11 (meiotic recombination 11 homolog) predict treatment-specific outcome of localised invasive bladder cancer.
B J U International (Online).
https://doi.org/10.1111/j.1464-410X.2012.11564.x
Bentzon, D. N., Borre, M., Ørntoft, T. F., Mortensen, M. M. & Andersen, L. D. (2012).
Expression Profiling of Hereditary versus Sporadic Prostate Cancer Suggests CYR61, EGR3, KLF6 and SNF1LK as Differentially Expressed Genes.
Open Journal of Urology, 45-54.
Schjørring, O.
, Kun, A., Flyvbjerg, A., Kirkeby, H. J., Jensen, J. B. & Simonsen, U. (2012).
Flow-Evoked Vasodilation Is Blunted in Penile Arteries from Zucker Diabetic Fatty Rats.
Journal of Sexual Medicine, 1789-1800.
https://doi.org/10.1111/j.1743-6109.2012.02743.xKrogstrup, N. V., Soendergaard, P., Secher, N. G., Ravlo, K., Keller, A. K., Toennesen, E., Bibby, B. M., Moldrup, U., Østraat, E. Ø.
, Pedersen, M., Jorgensen, T. M., Leuvenink, H.
, Norregaard, R., Birn, H., Marcussen, N. & Jespersen, B. (2012).
Improved GFR and renal plasma perfusion following remote ischaemic conditioning in a porcine kidney transplantation model.
Transplant International,
25(9), 1002-1012.
https://doi.org/10.1111/j.1432-2277.2012.01522.x
Bauer, S. B., Austin, P. F.
, Rawashdeh, Y. F., de Jong, T. P., Franco, I., Siggard, C.
, Jorgensen, T. M. & International Children's Continence Society (2012).
International Children's Continence Society's recommendations for initial diagnostic evaluation and follow-up in congenital neuropathic bladder and bowel dysfunction in children.
Neurourology and Urodynamics,
31(5), 610-4.
https://doi.org/10.1002/nau.22247Rawashdeh, Y. F., Austin, P., Siggaard, C., Bauer, S. B., Franco, I., de Jong, T. P.
, Jorgensen, T. M. & International Children's Continence Society (2012).
International children's continence society's recommendations for therapeutic intervention in congenital neuropathic bladder and bowel dysfunction in children.
Neurourology and Urodynamics,
31(5), 615-20.
https://doi.org/10.1002/nau.22248
Reid, A., Attard, G., Brewer, D., Miranda, S., Riisnaes, R., Clark, J., Hylands, L., Merson, S., Vergis, R., Jameson, C., Høyer, S.
, Sørensen, K. D., Borre, M., Jones, C., de Bono, J. S. & Cooper, C. S. (2012).
Novel, gross chromosomal alterations involving PTEN cooperate with allelic loss in prostate cancer.
Modern Pathology,
25(6), 902-910.
https://doi.org/10.1038/modpathol.2011.207Gammelager, H., Christiansen, C. F., Johansen, M. B., Borre, M., Schoonen, M.
& Sørensen, H. T. (2012).
Quality of urological cancer diagnoses in the Danish National Registry of Patients.
European Journal of Cancer Prevention,
21(6), 545-551.
https://doi.org/10.1097/CEJ.0b013e328351c680
Jensen, B. T., Dielenseger, P., Drudge-Coates, L., Flynn, K., Hieronymi, S., Erik van Muilekom, H. A. M., Pieters, R. & Voss, L. B. (2012).
Taking the lead: sharing best practice in intravenous bisphosphonate use in urological cancers.
European Journal of Oncology Nursing,
16(1), 42-53.
https://doi.org/10.1016/j.ejon.2011.02.006
Heidenreich, A., Witjes, W. P. J.
, Johansen, T. E. B., Patel, A. & EAU Research Foundation (2012).
Therapies used in prostate cancer patients by European urologists: data on indication with a focus on expectations, perceived barriers and guideline compliance related to the use of bisphosphonates.
Urologia Internationalis,
89(1), 30-8.
https://doi.org/10.1159/000338810Madsen, M. G., Nørregaard, R., Palmfeldt, J., Olsen, L. H., Frøkiær, J. & Jørgensen, T. M. (2012).
Urinary NGAL, cystatin C, β2-microglobulin, and osteopontin significance in hydronephrotic children.
Pediatric Nephrology,
27(11), 2099-2106.
https://doi.org/10.1007/s00467-012-2217-6
Stødkilde, L., Madsen, M. G., Palmfeldt, J., Topcu, S. O., Nørregaard, R., Olsen, L. H., Jørgensen, T. M. & Frøkiær, J. (2012).
Urinary proteome analysis in congenital bilateral hydronephrosis.
Scandinavian Journal of Urology and Nephrology.
https://doi.org/10.3109/00365599.2012.708669
Madsen, M. G., Nørregaard, R., Stødkilde-Jørgensen, L., Christensen, J. H., Jørgensen, T. M. & Frøkiær, J. (2012).
Urine and kidney cytokine profiles in experimental unilateral acute and chronic hydronephrosis.
Scandinavian Journal of Urology and Nephrology,
46(2), 91-96.
https://doi.org/10.3109/00365599.2011.637958
Munksgaard, P.
, Mansilla, F., Brems-Eskildsen, A. S., Fristrup, N., Birkenkamp-Demtröder, K., Ulhøi, B. P., Borre, M., Agerbæk, M., Hermann, GG.
, Ørntoft, T. F. & Andersen, L. D. (2011).
Low ANXA10 expression is associated with disease aggressiveness in bladder cancer. B J C,
105(9).
https://doi.org/10.1038/bjc.2011.404
